← Browse by Condition
Medical Condition

osteoarthritis hip

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for osteoarthritis hip sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — osteoarthritis hip Clinical Trials

How many clinical trials are currently recruiting for osteoarthritis hip?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for osteoarthritis hip, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteoarthritis hip?
osteoarthritis hip research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteoarthritis hip clinical trial?
Eligibility criteria for osteoarthritis hip trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
JointResearch 1 trial
Palo Alto Veterans Institute for Research 1 trial
University Health Network, Toronto 1 trial
Poznan University of Medical Sciences 1 trial
Sint Maartenskliniek 1 trial

Recruiting Clinical Trials

NCT04049279
Recruiting
Migration in Total Hip Arthroplasty with a Cemented BiMobile Cup: Better Stability with More Cement?
Enrollment
75 pts
Location
Netherlands
Sponsor
JointResearch
View Trial →
NCT05700682
Recruiting
Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee
Enrollment
120 pts
Location
United States
Sponsor
Palo Alto Veterans Institute f...
View Trial →
NCT06878417
Recruiting
Cannabinoids for Osteoarthritis Pain Effectiveness Trial
Enrollment
100 pts
Location
Canada
Sponsor
University Health Network, Tor...
View Trial →
NCT07581470
Recruiting
Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty
Enrollment
198 pts
Location
Poland
Sponsor
Poznan University of Medical S...
View Trial →
NCT06578182 Phase 3
Recruiting
The Effect of ColcHicine on the Incidence of Knee or Hip Replacements
Enrollment
1,410 pts
Location
Netherlands
Sponsor
Sint Maartenskliniek
View Trial →

Related Conditions

osteoarthritis knee (2) total hip arthroplasty (1) osteo arthritis shoulders (1) synovitis of knee (1) synovitis tenosynovitis hip (1) synovitis (1) pain chronic (1) osteoarthritis of knee (1) hip osteoarthritis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology